News and Blog

On Tuesday, December 8th, at 9am EST, AxoSim Consulting VP of Scientific Affairs, Thomas Hartung, MD, PhD, will be speaking on a Nature Research Custom Media Webcast: Translating Neurological Stem Cell Research into Therapies for […]

BENSON CAPITAL PARTNERS ANNOUNCES FIRST INVESTMENT IN AXOSIM, INC. AxoSim, Inc, Provider of BrainSim™ and NerveSim™ Neurological Drug Discovery Platforms Teams with Benson Capital Partners and Jefferson Capital Partners For Immediate Release: November 5, 2020 […]

October 30, 2020 –Two grants from the DoD Congressionally Directed Medical Research Program and the National Institutes of Health awarded to AxoSim–  –The CDMRP grant will support the development of a ALS NerveSim™ model to […]

AxoSim Scientist, Wesley Anderson, will be a Rapid Fire speaker at the 2020 AAPS PharmSci 360 Conference on Tuesday, November 3rd at 9:30am EST.  His presentation is titled Development and Qualification of a Novel In […]

On Wednesday, September 30th, AxoSim Lead Scientist, Anup Sharma, PhD, spoke at our interactive webinar: Human Schwann Cells: Importance for Peripheral Neuropathy Preclinical Research. During this webinar, Dr. Sharma spoke about AxoSim’s Human Peripheral Co-Culture […]

High Throughput, Human Data: AxoSim’s Human Peripheral Co-Culture Assay In addition to our 3D NerveSim™ and BrainSim™ models, AxoSim also performs a variety of cell-based 2D assays including our new Human Schwann Cell and iPSC-derived […]

Introducing our newest SimLab Service: Human Co-Culture Peripheral Assay We are excited to launch our newest assay which uses human Schwann cells and iPSC-derived neurons to recapitulate the results one can expect to see from […]

On Wednesday, September 16th at 11:00am EST, AxoSim CEO, Dr. Lowry Curley will be giving a dynamic poster presentation at Safety Pharmacology Society’s (SPS) Annual Meeting, held virtually this year.  The poster, #026, is entitled […]

Over 90% of neurological drugs that are successfully tested in animals fail once they reach human clinical trials. Therefore, there is a need for new, clinically relevant, preclinical testing models that mimic the human nervous […]

On July 28, 2020, AxoSim held a webinar which explored the need for new, predictive assays to better assess ADCs’ effects on peripheral neuropathy. Rakesh Dixit, PhD, DABT, elaborated on his 30 plus years of […]